Join us at the CIMIT Forum on March 8, 2011.
The CIMIT Accelerator program is focused on innovations that have a reasonable chance of being handed off to industry within twelve to eighteen months. This is a relatively short time, so the CIMIT Accelerator team works very intimately with the project team to not only advance the technology, but also to develop and execute a complete strategy for getting the solution into practice. In addition to investing cash, this includes determining the best way to spin out the technology (licensing, creating a new company, etc.), as well as doing market, competitive, financial and intellectual property analysis. The ideal accelerator project culminates with working prototypes, identified customers who are “ready to buy”, and a complete business plan that is fundable by outside parties (be they investors, established businesses or licensees).
This CIMIT Forum will present an overview of the Accelerator program:
New Model for Innovation
MICHAEL DEMPSEY
Entrepreneur in Residence and Leader of Accelerator Program, CIMIT
Michael Dempsey will introduce the program and give an overview of the selection criteria for the program, expectations and expected outcomes.
The Benefit of the CIMIT Accelerator to Entrepreneurs
STEVE SCHIEFEN
Founder and Chief Executive Officer, HanGenix
Steve Schiefen will overview his experiences as an entrepreneur and the CEO of one of the first companies spun out of the Accelerator.
Benefit to Academic Hospitals
FRANCES TONEGUZZO, PHD
Director of Research & Licensing, Massachusetts General Hospital, Research Ventures & Licensing (RVL), Partners HealthCare
Frances Toneguzzo will give an overview of the program from the perspective of the licensing offices of hospitals who have produced the base IP.
Benefit to Investors
M. JOSHUA TOLKOFF
Managing Director, Ironwood Capital
Josh Tolkoff will discuss the Accelerator from the perspective of a potential investor in the companies that are spun out of the Accelerator.
Learn more about this Forum and Speakers.
WHEN: Tuesday, March 8, 2011, 4:00 - 6:00 PM
WHERE: Massachusetts General Hospital, Simches
Comments